Vaxcyte Cash Flow Statement 2018-2024 | PCVX

Fifteen years of historical annual cash flow statements for Vaxcyte (PCVX).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021202020192018
$-402.27$-223.49$-100.08$-89.22$-50.27$-29.49
$-24.60$8.25$4.86$1.41$1.23$1.04
$48.76$31.90$10.83$5.91$-2.01$-3.91
$24.16$40.15$15.69$7.32$-0.78$-2.88
$0$0$0$0$0$0
$0$0$0$0$0$0
$11.23$2.90$-12.47$26.10$0.87$1.27
$33.80$2.67$-29.17$6.96$2.32$0.56
$81.32$12.74$-37.01$35.27$3.91$1.90
$-296.79$-170.60$-121.39$-46.63$-47.15$-30.47
$-16.06$-5.84$-6.53$-1.11$-1.20$-1.77
$0$0$0$0$0$0
$0$0$0$0$0$0
$-1,329.90$-102.75$-336.34$0$0$0
$624$183$131$0$0$0
$-705.43$80.43$-205.78$0$0$0
$-51.82$0$0$0$0$0
$-773.31$74.59$-212.31$-1.11$-1.20$-1.77
$0$0$0$264$-0.28$-0.28
$0$0$0$0$0$0
$0$0$0$264$-0.28$-0.28
$553$765$3.90$1.05$0.44$0.13
$553$765$3.90$1.05$0.44$0.13
$0$0$0$0$0$0
$86.87$96.44$13.90$110$41.40$62.35
$640$862$17.80$375$41.57$62.19
$-436.97$766$-316.34$327$-7.11$29.95
$48.76$23.65$10.73$5.43$1.19$0.75
$0$0$0$0$0$0